Who Makes Peptides: Manufacturers, CDMOs, and Where a New Brand Fits

When a founder first searches for peptide manufacturers, the results are disorienting. You find a mix of finished product retailers, catalog suppliers, contract manufacturers, and pharmaceutical companies all appearing in the same search results under headings like "top peptide companies" or "largest peptide manufacturers." It is genuinely hard to tell who makes the raw material, who repackages it, and who is simply a storefront. That confusion is not an accident of bad SEO. It reflects the fact that the peptide industry is genuinely layered, and each layer operates under different rules, sells to different customers, and has almost no reason to explain itself to a founder who is just starting out.

The short answer to the founder's question is this: peptides are manufactured across several distinct tiers. At the top sits pharmaceutical grade synthesis, carried out by contract development and manufacturing organizations (CDMOs) that describe their work as GMP grade and serve drug companies. Below that are research grade synthesis houses that produce peptides for scientific and research use. Below that are catalog research suppliers that buy bulk material and repackage it for researchers. And at the customer facing end of the chain sit private label and white label brands that build customer facing stores on top of material sourced from one or more of the tiers above. A new research use only (RUO) brand is usually a white label or private label brand that buys from the catalog supplier tier, not from the pharmaceutical manufacturing tier, and understanding why that is true is the entire point of this guide.

The Peptide Manufacturing Tiers: A Map of Who Does What

Before we can talk about where a new brand fits, we need a clear map of the industry. The word "manufacturer" gets applied loosely to every company in this chain, which is part of why search results are so confusing. A company that synthesizes peptide raw material from amino acid building blocks is doing something fundamentally different from a company that buys that material, tests it, and repackages it into vials for researchers. Both might call themselves manufacturers. Only one of them is doing synthesis.

Here is how we think about the tiers, from the top of the synthesis chain to the customer facing end.

Tier 1: Pharmaceutical Grade CDMOs and GMP Synthesis Houses

These are the companies that perform de novo peptide synthesis and describe their work as GMP grade. They serve pharmaceutical companies, biotech firms, and clinical research organizations. Their customers are regulated entities that need documented, auditable, traceable manufacturing for drug development and eventual regulatory submission.

The defining feature of this tier is not just the quality of the peptide. It is the entire quality system surrounding the synthesis. If a supplier uses the word GMP, ask what it covers. That documented quality system is expensive to build and maintain, and the cost is reflected in minimum order quantities and customer qualification requirements that tend not to fit a startup brand buying its first inventory.

Tier 2: Research Grade Synthesis Houses

These are companies that synthesize peptides for research and scientific use, without claiming GMP status. They may have significant analytical capabilities, including high performance liquid chromatography (HPLC) and mass spectrometry, and they typically provide certificates of analysis (CoAs) with purity data. They describe what they make as research material, and their customers are academic labs, biotech researchers, and commercial research suppliers.

Some research grade synthesis houses operate at substantial scale. Others are smaller custom synthesis shops that can produce novel sequences on demand. The research grade label does not mean low quality in any absolute sense. It means the supplier does not claim GMP status, so ask what documentation package comes with the material.

Tier 3: Catalog Research Suppliers

These are companies that buy synthesized peptide material, often from Tier 2 synthesis houses or from overseas manufacturers, and sell it under their own catalog with their own testing and quality documentation. They are not synthesizing peptides from scratch. They are sourcing, testing, and distributing. Their customers include research institutions, biotech companies, and commercial brands.

This is the tier where most new RUO brands actually begin their sourcing conversations. Catalog suppliers have lower minimums than CDMOs, they have established logistics for shipping research material, and they are accustomed to selling to commercial buyers who are not themselves pharmaceutical companies.

Tier 4: Private Label and White Label Brands

These are customer facing brands that source finished or semi finished product from the tiers above and sell it under their own brand identity. The distinction between private label and white label matters operationally. If you want to understand that distinction in depth before reading further, our guide at White Label Peptides vs Private Label Brands covers it thoroughly.

The key point here is that a white label or private label brand is not a manufacturer in the synthesis sense. It is a brand and distribution business built on top of someone else's manufacturing capability. That is not a weakness. It is the standard model for most consumer and research product categories. The brand's value is in customer trust, product curation, quality verification, and market positioning, not in owning a peptide synthesizer.

The Tier Map Table

The table below summarizes each tier across the dimensions that matter most to a founder deciding where to source.

This table is a starting framework, not a legal or regulatory classification. The lines between tiers can blur. Some research grade synthesis houses also offer catalog products. Some catalog suppliers have in house synthesis capability. The point is to give you a mental model for evaluating any supplier you encounter, not to give you a rigid taxonomy that every company will fit neatly into.

Why a New Brand Almost Never Buys From the Pharmaceutical Tier

This is the question founders ask most often after they discover that pharmaceutical grade CDMOs exist. The logic seems sound: if the highest quality peptides come from GMP manufacturers, why not just buy from them? The answer has three parts, and none of them are about quality preferences.

Customer Qualification Requirements

GMP manufacturers selling to pharmaceutical companies may qualify a customer before selling to it. Ask any CDMO what it requires. The manufacturer needs to know that the material they produce will be used in a manner consistent with their own quality system. A new brand without an established quality system, without a track record, and without the documentation infrastructure to support a quality agreement is simply not a qualified customer in their framework.

This is not a judgment about the founder's intentions. It is a structural feature of how these suppliers work. The CDMO's quality team will typically want to review your quality system and how you intend to use the material. Building that infrastructure takes time and resources that most startups do not have on day one.

Quality Agreements

A quality agreement is a formal contract between a manufacturer and its customer that defines the responsibilities of each party with respect to quality, testing, documentation, change notification, and regulatory compliance. A quality agreement specifies things like who is responsible for release testing, how deviations are communicated, what happens when a batch fails specification, and how changes to the manufacturing process are notified and approved. Ask each supplier whether it uses quality agreements.

For a GMP CDMO, entering into a quality agreement with a new brand that has no quality system to speak of is a risk management problem. The agreement would be largely one sided, and the CDMO's quality team would have no confidence that the downstream handling of their material would be consistent with the standards they maintain. A manufacturer at this tier may decline to engage rather than take on that risk.

Minimum Order Quantities

Even setting aside qualification and quality agreement requirements, the minimum order quantities at the pharmaceutical CDMO tier are calibrated for pharmaceutical customers. Those customers are buying material for clinical trials, commercial drug manufacturing, or large scale research programs. The quantities involved are much larger than what a new RUO brand needs for its initial inventory. A startup's first order is far smaller than what a facility built for drug company batches is set up to serve.

This is why the realistic entry point for a new brand is the catalog supplier tier or, in some cases, a research grade synthesis house that has experience working with commercial research brands. For more on how to evaluate those options, our guide at Peptide Supplier Vetting Checklist walks through the specific criteria we use.

What GMP Means and Why It Matters Even If You Are Not Buying GMP Material

GMP stands for good manufacturing practice. FDA's page on the topic says "CGMP refers to the Current Good Manufacturing Practice regulations enforced by the FDA." It adds that "CGMP provides for systems that assure proper design, monitoring, and control of manufacturing processes and facilities." In plain terms, GMP describes a documented, controlled way of making and releasing a drug, not a purity number, and a research grade label does not tell you whether that system was used. Do not treat GMP as a purity level. Judge any peptide by its analytical data, and ask counsel or a quality professional what GMP requires in your situation.

Whether GMP rules apply to you depends on what your product is, so check the current FDA pages on drug GMP before you rely on any assumption.

Under 21 CFR 201.128, intended use refers to objective intent, which may be shown by labeling claims, advertising matter, or oral or written statements by the persons responsible or their representatives. Ask counsel how drug GMP rules apply to you.

Knowing what GMP means also helps you evaluate the claims that suppliers make. A supplier that says its products are "pharmaceutical grade" or "GMP quality" without being able to point to a specific certification or audit has given you a phrase, not evidence. Knowing the difference protects you from paying a premium for a claim that has no verifiable substance behind it.

Research Grade vs. GMP: A Practical Comparison

Research grade peptides are manufactured for use in scientific research. The quality standard is fitness for research purpose, which typically means high purity (as measured by HPLC), correct molecular identity (as confirmed by mass spectrometry), and consistent lot to lot performance. Some research grade suppliers publish strong analytical results, and you should verify them independently. The material may not come with batch records or other documentation a pharmaceutical customer would ask for. Ask what documentation comes with each lot.

For an RUO brand, the relevant quality question is not "is this GMP?" but rather "can the supplier provide a credible certificate of analysis with HPLC purity data and mass spec confirmation, and can I verify that data independently?" Third party testing is the practical quality assurance tool for brands operating at the research grade tier. Our supplier vetting guide at Peptide Supplier Vetting Checklist covers how to structure that verification process.

What a Quality Agreement Is and Whether You Need One

As described above, a quality agreement sets out who is responsible for testing, documentation, and change notification. At the research grade and catalog supplier tier, ask whether a supplier uses quality agreements at all.

For a new brand buying from a catalog supplier, you may not be asked to sign a formal quality agreement. But the concept behind a quality agreement, which is a clear, documented understanding of who is responsible for what in terms of testing, documentation, and quality assurance, is still useful. When you are evaluating a supplier, asking questions that a quality agreement would answer (who performs release testing, how are out of specification results handled, how are you notified of changes to the manufacturing process) tells you a great deal about how seriously the supplier takes quality management.

Why Online Rankings of "Top Peptide Companies" Are Not Useful

If you have spent any time searching for peptide manufacturers, you have encountered articles with titles like "Top Peptide Companies" or "Largest Peptide Manufacturers in the World." These lists are almost universally useless for a founder trying to understand the supply chain, and it is worth understanding why.

They Mix Tiers Without Distinguishing Them

A list that puts a pharmaceutical CDMO, a research grade synthesis house, a catalog supplier, and a consumer facing brand in the same ranking is not comparing like with like. These companies are not competing for the same customers. They are not operating in the same regulatory environment. They are not even doing the same thing. Ranking them together is like ranking a steel mill, a hardware distributor, a hardware store, and a contractor in the same "top construction companies" list. The categories are different enough that a ranking is meaningless.

They Rarely Cite Primary Data

A ranking without a methodology and a primary data source is an opinion dressed up as analysis. Market size, revenue, and production capacity data for private companies in the peptide industry are not publicly available in any comprehensive form. Any list that ranks companies by size without citing audited financial data or a credible market research source is making claims it cannot support. We do not invent statistics, and we are skeptical of any source that does.

They Often Reflect SEO, Not Industry Reality

Many "top peptide company" lists are generated by content farms optimizing for search traffic, not by industry analysts with access to supply chain data. The companies that appear on those lists are often the ones with the best SEO, the most affiliate relationships with the list publisher, or the most aggressive marketing budgets. None of those factors tell you anything about manufacturing quality, supply chain reliability, or suitability as a supplier for your brand.

What to Do Instead

Instead of relying on rankings, evaluate suppliers against a consistent set of criteria: analytical documentation, third party testing, regulatory compliance history, import alert status, minimum order flexibility, and communication quality. Our guide at Peptide Supplier Vetting Checklist gives you a structured framework for doing exactly that. For context on why import alert status matters, see our guide at FDA Import Alert 66-40: Check a Peptide Supplier.

The Role of Chinese Manufacturers in the Research Grade Supply Chain

The company that sells a research grade peptide is often not the company that made it. Some US based catalog suppliers and research grade distributors source their material from overseas synthesis houses, and some US brands buy directly from overseas manufacturers. Ask each supplier where its product is made.

Buying from a US based catalog supplier that sources from China gives you a domestic point of contact and, in some cases, domestic testing. The tradeoff is a higher per unit cost and less visibility into the original manufacturing source.

Buying directly from a Chinese manufacturer can reduce per unit costs and give you more direct control over the supplier relationship. The tradeoffs include more complex import logistics, greater due diligence burden, and the need to check the current FDA import alert pages for any supplier you consider.

Our guide at Sourcing Peptides from China: What US Sellers Need to Know covers both approaches in depth, including the practical considerations for each. For pricing context across the supply chain, our guide at Peptide Wholesale Price List: MOQs, Tiers and Quotes covers how pricing typically varies by tier and volume.

How to Evaluate a Supplier Without Being Able to Visit Their Facility

Most new brands are not going to fly to a supplier's facility for an in person audit. That is a realistic constraint, not a failure of diligence. The question is how to do meaningful supplier evaluation remotely, and the answer is to focus on the documents and behaviors that a legitimate supplier will produce without hesitation.

Step 1: Request a Certificate of Analysis for a Specific Lot

A credible supplier should be able to provide a CoA for any product they are currently selling. The CoA should include HPLC purity data, mass spectrometry confirmation of molecular identity, lot number, and synthesis date. If a supplier cannot produce a CoA on request, or if the CoA they provide lacks HPLC and mass spec data, that is a disqualifying failure.

Pass check: CoA received within a reasonable timeframe, includes HPLC purity percentage and mass spec data, references a specific lot number.

Fail check: No CoA available, CoA lacks analytical data, or CoA appears to be a generic template not tied to a specific lot.

Step 2: Send a Sample for Independent Third Party Testing

Do not rely solely on the supplier's own CoA. Send a sample to an independent analytical laboratory for HPLC purity testing and mass spec confirmation. Weigh the cost of this testing against the cost of stocking inventory that does not meet specification. If the independent test results match the supplier's CoA within a reasonable tolerance, that is a meaningful positive signal. If they diverge significantly, you have learned something important before committing to a larger order.

Pass check: Independent test results confirm purity and identity within acceptable tolerance of supplier's CoA.

Fail check: Significant divergence between independent results and supplier's CoA, or supplier objects to independent testing.

Step 3: Check Import Alert Status

The FDA publishes import alerts. Import Alert 66-40 is titled "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"; read the alert itself on the FDA site to see how it applies. A supplier whose products are subject to an active import alert creates supply chain risk for your brand regardless of the product's analytical quality. Our guide at FDA Import Alert 66-40: Check a Peptide Supplier explains how to check this.

Pass check: Supplier and relevant products not listed on active import alerts.

Fail check: Supplier or products appear on FDA import alert database.

Step 4: Evaluate Communication Quality and Responsiveness

A supplier's communication behavior during the sales process is a proxy for how they will behave when something goes wrong. A supplier that responds promptly, answers technical questions accurately, and provides documentation without being asked repeatedly is demonstrating operational competence. A supplier that is evasive about manufacturing details, slow to provide documentation, or unable to answer basic questions about their synthesis process is showing you something important.

Pass check: Prompt, accurate, technically credible responses to questions about synthesis, testing, and documentation.

Fail check: Evasive answers, inability to explain analytical data, or pressure to commit to an order before documentation is provided.

Step 5: Assess Minimum Order Flexibility and Scalability

Your first order from a new supplier should be small enough to test the relationship without overcommitting capital. A supplier that insists on large minimums for a first order from an unproven customer is either not calibrated for the research brand market or is trying to lock in revenue before you have had a chance to verify quality. Reasonable suppliers understand that new customers need to validate the relationship before scaling.

Pass check: Supplier offers a meaningful trial order quantity that allows quality verification before a larger commitment.

Fail check: Supplier requires large minimum orders with no flexibility for new customer qualification orders.

Understanding Accreditation and What It Actually Tells You

Suppliers in the research grade tier sometimes reference accreditations or certifications as quality signals. Ask each supplier what a certificate or accreditation covers before you rely on it. If a supplier says its laboratory is accredited, ask which standard and which accreditation body, and verify the status with that body directly. A certificate is not a product guarantee.

An accreditation is one data point and not a substitute for your own testing.

Where White Label and Private Label Brands Fit in This Picture

We have described the manufacturing tiers from the top down. Now let us be explicit about where a new brand sits and what that means operationally.

A new RUO brand is almost always a Tier 4 business: a brand and distribution operation built on top of material sourced mainly from Tier 3, and sometimes from Tier 2. That is not a limitation. It is a common operating model for research product brands. The brand's competitive advantage is not in synthesis chemistry. It is in product curation, quality verification, customer trust, marketing, and operational execution.

The practical implication is that your job as a brand operator is not to become an expert in peptide synthesis. It is to become an expert in supplier evaluation, quality verification, regulatory compliance for RUO products, and customer communication. Those are the skills that determine whether your brand succeeds, not whether you own a synthesizer.

The distinction between white label and private label matters here because it affects how much control you have over the product specification and how differentiated your brand can be. A white label arrangement typically means you are selling a pre-existing product under your brand name with minimal ability to specify the product. A private label arrangement typically gives you more control over specification, testing requirements, and packaging. Our guide at White Label Peptides vs Private Label Brands covers the operational and strategic implications of each approach in detail.

The Documentation Stack a New Brand Should Build

Even if you are not manufacturing peptides yourself, you need a documentation infrastructure that supports your brand's quality claims and supports you operationally. Here is the core documentation stack we recommend building from day one.

Supplier Documentation File

For each supplier you work with, maintain a file that includes: the supplier's CoA for each lot you purchase, your independent third party test results for each lot, any quality related correspondence with the supplier, and records of any quality issues and how they were resolved. This file is your record of the diligence you did when sourcing. It is also the foundation of any quality agreement or supplier qualification process you develop as your brand scales.

Product Specification Documents

For each product you sell, maintain a written specification that defines the acceptable purity range, the required analytical tests, the packaging and labeling requirements, and the intended use statement (research use only). This document is the standard against which you evaluate incoming material and the basis for any dispute with a supplier about product quality.

Lot Traceability Records

Maintain records that allow you to trace any unit of product you sell back to the specific lot it came from, and from that lot back to the supplier and the CoA. If a quality issue arises after a product has been sold, lot traceability is what allows you to identify the scope of the issue and take appropriate action.

Intended Use Documentation

Your products are research use only. That designation needs to be reflected consistently in your product listings, your invoices, your shipping documentation, and your customer communications. Ask counsel how far your research use only labeling protects you.

Pricing Across the Tiers and What It Tells You

Pricing in the peptide supply chain varies significantly across tiers, and understanding the general structure helps you evaluate whether a supplier's pricing is consistent with their claimed position in the supply chain.

GMP pharmaceutical grade material is the most expensive, reflecting the cost of the quality system, documentation infrastructure, and regulatory compliance overhead. Research grade material from a well equipped synthesis house is less expensive, reflecting lower regulatory overhead but still significant analytical capability. Catalog supplier pricing reflects the synthesis cost plus the supplier's margin for testing, packaging, and distribution. White label and private label pricing at the brand level reflects all of the above plus brand margin.

If a supplier claims to be producing GMP quality material but is pricing at catalog supplier levels, that is a signal worth investigating. Either their quality claims are inflated, their cost structure is genuinely different from what you would expect, or they are subsidizing customer acquisition with unsustainable pricing. None of those scenarios is necessarily disqualifying, but all of them warrant additional scrutiny.

Conversely, if a catalog supplier is pricing significantly above what you would expect for research grade material without a clear explanation (proprietary testing, domestic synthesis, specific accreditations), you should understand what you are paying for before committing.

Our guide at Peptide Wholesale Price List: MOQs, Tiers and Quotes covers pricing structures across the supply chain in more detail and gives you a framework for evaluating whether the pricing you are seeing is consistent with the supplier's claimed tier.

Building Supplier Relationships That Scale

The supplier relationship you build in your first year will shape your brand's trajectory for years afterward. A few principles we have found useful.

Start with more than one supplier. Relying on a single supplier for your entire inventory creates concentration risk. If that supplier has a quality issue, a logistics problem, or a regulatory complication, your entire inventory pipeline is affected. Building relationships with more than one supplier for your core products gives you redundancy and negotiating leverage.

Communicate quality expectations clearly and early. Do not assume that a supplier understands your quality requirements. Put them in writing, reference them in every order, and follow up when material arrives. A supplier that consistently meets your documented quality requirements is a supplier worth investing in. A supplier that consistently falls short of documented requirements is a supplier you should be transitioning away from, regardless of their pricing.

Treat supplier relationships as long term partnerships, not transactional purchases. Suppliers who know you, trust you, and value your business are more likely to give you early warning of supply issues, prioritize your orders during capacity constraints, and work with you to resolve quality issues when they arise. That relationship value is real and worth investing in.

Document everything. Every quality issue, every resolution, every change in specification or packaging, every communication about a quality concern. Documentation helps you operationally, and it gives you the data you need to make informed decisions about your supplier relationships over time.

Regulatory Context for RUO Brands

Operating as an RUO brand does not mean operating outside of regulatory oversight. Ask counsel which FDA rules apply to your products.

Do not assume the words research use only settle your regulatory position. Under 21 CFR 201.128, the intent of the persons legally responsible for the labeling may be shown by their expressions, the design or composition of the article, or the circumstances of its distribution, so your marketing and labeling should be consistent with a research purpose. So do not make claims about your products' effects on human health, disease, or physiology.

Import alerts are a practical consideration for brands sourcing from overseas manufacturers. The FDA publishes import alerts, including Import Alert 66-40, titled "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs". Checking whether your suppliers appear on a relevant alert is a basic due diligence step. Our guide at FDA Import Alert 66-40: Check a Peptide Supplier covers this in detail.

The FTC publishes pages titled "Health Products Compliance Guidance" and "Endorsements, Influencers, and Reviews". Read both on ftc.gov before you write marketing claims about quality, purity, or performance, do not make health or medical claims for an RUO product, and ask counsel what applies to you.

Frequently Asked Questions

Can I just buy from a pharmaceutical peptide manufacturer?

The direct answer is that these companies serve pharmaceutical customers, and a new RUO brand is almost certainly not a qualified customer in their framework. Pharmaceutical CDMOs may ask for customer qualification and quality agreements, and their minimum order quantities may be calibrated for drug companies, not research brands. Even if you could navigate the qualification process, the minimum orders would likely be far larger than what a new brand needs. Your realistic entry point is the catalog supplier or research grade synthesis house tier, not the pharmaceutical CDMO tier.

What is the difference between a CDMO and a regular peptide manufacturer?

A CDMO (contract development and manufacturing organization) provides manufacturing services to other companies rather than manufacturing products under its own brand. A CDMO's customers own the product and the intellectual property. The CDMO provides the manufacturing capability, quality system, and regulatory documentation. A "regular" peptide manufacturer might produce and sell products under its own catalog, making it both a manufacturer and a brand.

How do I know if a supplier is actually manufacturing the peptides or just reselling them?

Ask directly. Ask the supplier whether they perform in house synthesis or source from a third party manufacturer. Ask for the name and location of the synthesis facility. Ask whether they can provide documentation from the original synthesis, not just their own repackaging CoA. A supplier that is genuinely manufacturing will be able to answer these questions specifically and confidently. A supplier that is reselling will often be evasive or vague about the original manufacturing source. You can also look for signals in the documentation: a CoA that references a specific synthesis facility and lot number is more credible than a generic document that only references the reseller's own brand.

What documents should I always ask for before placing a first order?

At minimum, request a certificate of analysis for a current lot that includes HPLC purity data and mass spectrometry confirmation of molecular identity. Also ask for the supplier's quality policy or quality manual (even a brief one), their process for handling out of specification results, and any relevant accreditation certificates. Before committing to a larger order, send a sample for independent third party testing. The combination of the supplier's CoA and an independent verification gives you a meaningful quality baseline.

Why do so many "top peptide company" lists include consumer brands alongside manufacturers?

Because those lists are almost never produced by people with supply chain expertise. They are typically produced by content publishers optimizing for search traffic, and they pull together any company that appears in search results for peptide related terms. Consumer brands, catalog suppliers, research grade manufacturers, and pharmaceutical CDMOs all appear in peptide related searches, so they all end up on the same list. The list publisher rarely has the industry knowledge to distinguish between them, and the ranking criteria (if any are stated) are usually proxies for SEO performance rather than manufacturing capability or supply chain position.

Is research grade the same as low quality?

No. Research grade refers to how the supplier describes its material, not to the analytical quality of the product. A well run research grade synthesis house with modern HPLC and mass spectrometry capabilities can produce material with very high purity and confirmed molecular identity. Research grade and GMP differ in the quality system and documentation behind the material, and a research grade label does not tell you which controls were used. For an RUO brand, the relevant quality question is whether the material meets your analytical specification, which you verify through CoA review and independent testing, not whether it was manufactured under GMP conditions.

Can I build a quality agreement with a catalog supplier even if they do not require one?

Yes, and in many cases it is worth proposing one even if the supplier does not have a standard template. A quality agreement does not need to be a complex pharmaceutical style document. At the research brand tier, it can be a straightforward written agreement that specifies the analytical standards the supplier commits to meeting, the documentation they will provide with each lot, the process for handling out of specification results, and the notification requirements for changes to their manufacturing or sourcing. Having this in writing protects both parties and signals to the supplier that you are a serious, quality focused customer, which often improves the quality of service you receive.

If you are working through these questions for your own brand and want a structured conversation about where you are in the process and what your next steps should be, we are happy to talk it through. Book a fit call at peptideecommerce.com and we can talk through your specific situation.

Sources

The regulatory points above come from the primary sources listed below. The tier descriptions are our general industry framing, not regulatory classifications. Founders seeking primary regulatory source material should consult the FDA's guidance documents at fda.gov and the FTC's advertising guidance at ftc.gov.

• FDA, Import Alert 66-40: https://www.accessdata.fda.gov/cms_ia/importalert_189.html
• FDA, Facts About the Current Good Manufacturing Practice (CGMP): https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practice-cgmp
• FTC, Health Products Compliance Guidance: https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance

This article is not legal advice. It is an operational guide for founders building research use only peptide ecommerce brands. Consult qualified legal counsel for advice specific to your business and jurisdiction.